Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine today (Saturday). The results...
Tag: <span>Prostate cancer</span>
Post
Prostate cancer treatment ‘could help more patients’
Image captionHormone therapy stops more testosterone from reaching the prostate gland One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers. A drug for treating prostate cancer that has spread was found to save lives when offered earlier, a study found. The trial looked at abiraterone as an additional...
Post
Scientists identify biomarkers to guide hormone therapy for prostate cancer
A test commonly used in breast cancer has been found to also identify which patients with aggressive prostate cancer will benefit from hormonal therapy, according to a study led by scientists at UC San Francisco and the University of Michigan. While hormone therapy has been used successfully to treat many prostate cancer patients, until now, researchers have been...
Post
New blood test is more accurate in predicting prostate cancer risk than PSA
Eric Klein, M.D., is chair of Cleveland Clinic’s Glickman Urological & Kidney Institute. A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial...
Post
Will we soon have a jab for prostate cancer? Experts unveil a vaccine that could provide a cure for the disease
Vaccine that treats the disease by stimulating the immune system is being tested Jab stopped tumours from spreading for 77% of cancer patients in the trial And 45 per cent of patients in the clinical trial experienced tumour shrinkage Prostate cancer is one of the most common cancers, affecting one in seven men A vaccine...
Post
Advanced prostate cancer treatment failure due to cell reprogramming
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Columbia University Medical Center (CUMC) researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy. The findings, based on a study in mice, could help to determine which patients should...
Post
Thousands of men with prostate cancer get risky treatment they don’t need. New approaches could curb that
Precise MD uses fluorescent biomarkers and other features to tell harmless prostate cancer cells from aggressive ones.MOUNT SINAIThey look like glowing jade necklaces of such unearthly brilliance they could be a Ming emperor’s. But if Dr. Gerardo Fernandez is right, the green fluorescent images of prostate cells could be even more valuable, at least to...
Post
Men with prostate cancer can now be saved by a ‘wonder drug’ which boosts survival rates for women battling breast tumours
Research suggests a new ‘wonder drug’ could help men with prostate cancer The pill boosts survival in women battling genetic breast and ovarian cancer American actor Ben Stiller, 51, revealed he had been diagnosed with the disease A ‘wonder drug’ that boosts survival in women battling genetic breast and ovarian cancer may also be a...
Post
Should you get screened for prostate cancer? We break down the latest advice
A panel of experts in preventive medicine released a draft proposal Tuesday on screening for prostate cancer. “Another one?” you may ask, remembering an earlier recommendation. Don’t worry; we’re here to help you avoid whiplash: What’s new? What was emphatic before is wishy-washy now. The last time the US Preventive Services Task Force weighed in on prostate cancer...
Post
Study provides path for new immunotherapy approaches to prostate cancer
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an immune attack after one immunotherapy drug fires up the immune system, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine. Based...